Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 15(3): e0222619, 2020.
Article in English | MEDLINE | ID: mdl-32150577

ABSTRACT

Ion channels have recently attracted attention as potential mediators of skin disease. Here, we explored the consequences of genetically encoded induction of the cell volume-regulating Ca2+-activated KCa3.1 channel (Kcnn4) for murine epidermal homeostasis. Doxycycline-treated mice harboring the KCa3.1+-transgene under the control of the reverse tetracycline-sensitive transactivator (rtTA) showed 800-fold channel overexpression above basal levels in the skin and solid KCa3.1-currents in keratinocytes. This overexpression resulted in epidermal spongiosis, progressive epidermal hyperplasia and hyperkeratosis, itch and ulcers. The condition was accompanied by production of the pro-proliferative and pro-inflammatory cytokines, IL-ß1 (60-fold), IL-6 (33-fold), and TNFα (26-fold) in the skin. Treatment of mice with the KCa3.1-selective blocker, Senicapoc, significantly suppressed spongiosis and hyperplasia, as well as induction of IL-ß1 (-88%) and IL-6 (-90%). In conclusion, KCa3.1-induction in the epidermis caused expression of pro-proliferative cytokines leading to spongiosis, hyperplasia and hyperkeratosis. This skin condition resembles pathological features of eczematous dermatitis and identifies KCa3.1 as a regulator of epidermal homeostasis and spongiosis, and as a potential therapeutic target.


Subject(s)
Eczema/genetics , Epidermis/pathology , Intermediate-Conductance Calcium-Activated Potassium Channels/genetics , Intermediate-Conductance Calcium-Activated Potassium Channels/metabolism , Keratosis/genetics , Skin/metabolism , Transgenes , Acetamides/pharmacology , Animals , Cytokines/metabolism , Doxycycline/pharmacology , Eczema/drug therapy , Female , Homeostasis/genetics , Hyperplasia/drug therapy , Hyperplasia/genetics , Intermediate-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Keratinocytes/metabolism , Keratosis/drug therapy , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Trans-Activators/metabolism , Trityl Compounds/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...